HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kyung-Tae Lee Selected Research

arvelexin

1/2023Protective effect of 7-hydroxyl-1-methylindole-3-acetonitrile on the intestinal mucosal damage response to inflammation in mice with DSS-induced colitis.
8/2012Arvelexin inhibits colonic inflammation by suppression of NF-κB activation in dextran sulfate sodium-induced mice and TNF-α-induced colonic epithelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kyung-Tae Lee Research Topics

Disease

66Neoplasms (Cancer)
02/2024 - 12/2002
27Leukemia
10/2023 - 08/2002
25Edema (Dropsy)
01/2023 - 02/2002
22Inflammation (Inflammations)
12/2023 - 05/2006
14Colitis
07/2023 - 07/2011
14Ovarian Neoplasms (Ovarian Cancer)
01/2020 - 04/2011
10Lung Neoplasms (Lung Cancer)
10/2021 - 03/2014
10Septic Shock (Toxic Shock Syndrome)
10/2016 - 09/2011
9Body Weight (Weight, Body)
01/2023 - 11/2010
8Endotoxemia
12/2023 - 09/2012
7Rheumatoid Arthritis
12/2023 - 06/2002
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2022 - 01/2017
6Meningoencephalitis
01/2020 - 06/2014
5Colonic Neoplasms (Colon Cancer)
05/2024 - 01/2015
5Arthritis (Polyarthritis)
12/2023 - 02/2002
5Infections
12/2020 - 10/2013
5Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2019 - 01/2010
4Obesity
12/2023 - 01/2022
4Hypertension (High Blood Pressure)
10/2022 - 02/2011
4Mitochondrial Diseases (Mitochondrial Disease)
11/2018 - 01/2010
4Sepsis (Septicemia)
10/2016 - 06/2015
4Endometrial Neoplasms (Endometrial Cancer)
09/2016 - 08/2011
4Carcinoma (Carcinomatosis)
05/2015 - 09/2010
4Cognitive Dysfunction
01/2014 - 09/2007
4Necrosis
12/2012 - 05/2005
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
07/2023 - 01/2019
3Atherosclerosis
10/2022 - 06/2007
3Hyperlipidemias (Hyperlipidemia)
02/2022 - 06/2007
3Ulcerative Colitis
02/2020 - 07/2011
3Hemorrhage
01/2018 - 07/2011
3Adenocarcinoma of Lung
07/2014 - 12/2012
3Acute Promyelocytic Leukemia
05/2005 - 11/2002
2Prostatic Neoplasms (Prostate Cancer)
12/2023 - 12/2016
2Colorectal Neoplasms (Colorectal Cancer)
12/2023 - 09/2010
2Neoplasm Metastasis (Metastasis)
12/2023 - 01/2018
2Pain (Aches)
07/2023 - 01/2016

Drug/Important Bio-Agent (IBA)

23CarrageenanIBA
07/2023 - 06/2002
20Proteins (Proteins, Gene)FDA Link
01/2023 - 08/2002
13LipopolysaccharidesIBA
12/2023 - 09/2011
10Dextran SulfateIBA
07/2023 - 07/2011
8Ethanol (Ethyl Alcohol)IBA
10/2023 - 06/2008
8CytokinesIBA
08/2022 - 09/2012
8CaspasesIBA
10/2021 - 11/2008
8Phosphotransferases (Kinase)IBA
10/2020 - 11/2010
8Messenger RNA (mRNA)IBA
03/2020 - 01/2015
8Acetic Acid (Vinegar)FDA LinkGeneric
12/2011 - 07/2003
7Transcription Factor AP-1 (Transcription Factor AP 1)IBA
01/2023 - 01/2013
7Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
08/2022 - 07/2010
7TriterpenesIBA
02/2022 - 05/2006
7Cisplatin (Platino)FDA LinkGeneric
10/2021 - 01/2011
6LipidsIBA
09/2022 - 01/2005
6Reactive Oxygen Species (Oxygen Radicals)IBA
07/2015 - 10/2003
5Dinoprostone (PGE2)FDA Link
10/2023 - 05/2005
5Dextrans (Dextran)FDA Link
07/2023 - 12/2014
5sodium sulfate (sodium bisulfate)FDA LinkGeneric
07/2023 - 12/2014
5Cyclooxygenase 2 (Cyclooxygenase-2)IBA
08/2022 - 09/2012
5T-Type Calcium Channels (T-Type Calcium Channel)IBA
10/2021 - 11/2010
5Caspase 8 (Caspase-8)IBA
12/2018 - 11/2008
5Interleukin-6 (Interleukin 6)IBA
01/2017 - 04/2009
5Paclitaxel (Taxol)FDA LinkGeneric
04/2014 - 09/2010
5costunolideIBA
12/2011 - 08/2002
4AntioxidantsIBA
12/2023 - 08/2010
4Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2023 - 05/2005
4Hormones (Hormone)IBA
09/2022 - 04/2011
4Cytochromes c (Cytochrome c)IBA
10/2021 - 09/2010
4Analgesics (Analgesic Drugs)IBA
06/2020 - 10/2004
4Peroxidase (Myeloperoxidase)IBA
02/2020 - 07/2011
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 11/2011
4SesquiterpenesIBA
09/2015 - 11/2002
4FlavonoidsIBA
05/2013 - 09/2010
4Indicators and Reagents (Reagents)IBA
05/2006 - 02/2002
3Antineoplastic Agents (Antineoplastics)IBA
12/2023 - 02/2020
3hydrangenolIBA
12/2023 - 10/2019
3pelubiprofenIBA
07/2023 - 12/2011
3CholesterolIBA
10/2022 - 01/2005
3Neuroprotective AgentsIBA
10/2022 - 05/2009
3Glucose (Dextrose)FDA LinkGeneric
02/2022 - 09/2016
3oxidized low density lipoproteinIBA
03/2021 - 04/2008
3CollagenIBA
10/2019 - 02/2008
3ResveratrolIBA
02/2019 - 05/2015
3Caspase 3 (Caspase-3)IBA
12/2018 - 12/2016
3DNA (Deoxyribonucleic Acid)IBA
01/2018 - 09/2007
3Annexin A5IBA
09/2016 - 05/2012
3Methanol (Carbinol)IBA
12/2015 - 02/2002
3NF-kappa B (NF-kB)IBA
11/2015 - 01/2011
3KYS 05090IBA
07/2014 - 12/2013
3SaponinsIBA
02/2013 - 06/2007
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2012 - 05/2005
3Prostaglandins EIBA
03/2012 - 04/2009
3LactonesIBA
12/2011 - 11/2002
3Cholinergic Agents (Cholinergics)IBA
06/2010 - 09/2007
3Scopolamine (Hyoscine)FDA Link
06/2010 - 09/2007
3C-Reactive ProteinIBA
05/2006 - 10/2003
2Small Interfering RNA (siRNA)IBA
05/2024 - 09/2014
2CateninsIBA
05/2024 - 12/2023
2Matrix Metalloproteinases (MMPs)IBA
05/2024 - 09/2017
2AmidesIBA
10/2023 - 01/2017

Therapy/Procedure

15Oral Administration
12/2023 - 10/2003
8Therapeutics
07/2023 - 09/2004
6Traditional Medicine (Folk Remedies)
10/2019 - 05/2012